Martek Casts For CHD Reduction Claim For Fish Oils, Big Disclaimer For Fish
This article was originally published in The Tan Sheet
Fish oil products and supplements containing omega-3 fatty acids would be exempt from lengthy disclaimers when using qualified coronary heart disease reduction claims, while fish would not, under a proposal submitted to FDA by Martek Biosciences
You may also be interested in...
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
FDA should amend the approved health claim linking omega-3 fatty acids to a reduced risk of coronary heart disease by removing the disclaimer and extending the claim to foods, supplement industry members maintain in a June 23 petition
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC